Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein

Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein

US Patent 9840550 · Granted Dec 12, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelop2021
Antiretroviral drug targeting human endogenous retrovirus2021
Antiretroviral drug targeting human endogenous retrovirus2021
Antiretroviral drug targeting human endogenous retrovirus2021
Compounds for treating the remyelination blockade in diseases associated with th2020
Compounds for treating the remyelination blockade in diseases associated with th2020
Compounds for treating the remyelination blockade in diseases associated with th2020
Compounds for treating the remyelination blockade in diseases associated with th2020
Compounds for treating the remyelination blockade in diseases associated with th2020
Compounds for treating the remyelination blockade in diseases associated with th2020
Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by ne2020
IgG stimulated remyelination of peripheral nerves2019